Adults Final Actual Exam Prep Document | 2026/2027 Edition
| 250 Verified Questions
NRNP 6560 Final Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously curated for graduate-level nurse
practitioner students enrolled in NRNP 6560 at Walden University. It contains 250 verified questions
and answers that reflect the actual final exam content, ensuring alignment with the 2026/2027
academic year curriculum. The material covers essential topics in advanced nursing care of adults and
older adults, including complex chronic conditions, pharmacotherapeutics, and evidence-based
practice. Each question is accompanied by a rationale to reinforce critical thinking and clinical
reasoning. This resource is designed to facilitate mastery and confidence for exam success.
Key Features:
Comprehensive coverage of acute and chronic illness management in adults and older adults
In-depth focus on pharmacotherapeutics and polypharmacy considerations
Evidence-based screening and diagnostic criteria for geriatric syndromes
Patient-centered care planning and health promotion strategies
Ethical and legal issues in advanced practice nursing
Updated to reflect 2026/2027 clinical practice guidelines
Updates for 2026:
- Integrated latest updates from the American Geriatrics Society (AGS) Beers Criteria
- Revised to include new hypertension and diabetes management guidelines
- Enhanced content on telehealth and remote monitoring in geriatric care
- Added questions on COVID-19 long-term effects and management
- Incorporated updated immunization schedules for older adults
Abstract:
This exam preparation document for NRNP 6560 provides a rigorous and comprehensive review of advanced
nursing care for adult and older adult populations. It synthesizes current evidence-based guidelines,
pharmacological principles, and holistic care approaches essential for nurse practitioner practice. The 250
questions are strategically distributed across key content areas, including cardiovascular, respiratory,
neurological, and endocrine disorders, as well as geriatric syndromes and palliative care. Each question is
designed to assess clinical judgment, differential diagnosis, and treatment planning at an advanced level.
Rationales are provided to deepen understanding and application of concepts. This resource is an indispensable
tool for graduate students aiming to excel in their final exam and future clinical practice.
Keywords:
NRNP 6560, Advanced Nursing Care, Adults and Older Adults, Final Exam, Walden University, Nurse
Practitioner, Geriatric Syndromes, Pharmacotherapeutics
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale explaining why it is correct and why the other options are incorrect. This format
enhances understanding of underlying concepts and promotes critical thinking.
Compliance Checklist:
Page 1
, Aligned with Walden University's NRNP 6560 course objectives
Reflects 2026/2027 academic year curriculum updates
Incorporates latest evidence-based practice guidelines
Reviewed by subject matter experts in geriatric nursing
Includes rationales for all answers to support learning
Suitable for graduate-level nurse practitioner students
Content Area Overview:
Content Area Questions Key Topics Weight
Cardiovascular and Hematologic 1-50 Hypertension, Heart Failure, Arrhythmias, 20%
Disorders Anemia, Anticoagulation
Respiratory and ENT Disorders 51-90 COPD, Asthma, Pneumonia, Sleep Apnea, 16%
Allergic Rhinitis
Endocrine and Metabolic 91-130 Diabetes Mellitus, Thyroid Disorders, 16%
Disorders Osteoporosis, Electrolyte Imbalances
Neurological and Psychiatric 131-170 Stroke, Dementia, Depression, Anxiety, 16%
Disorders Parkinson's Disease
Renal, Hepatic, and 171-210 Chronic Kidney Disease, Cirrhosis, GERD, 16%
Gastrointestinal Disorders Constipation, Diverticulitis
Geriatric Syndromes and 211-250 Falls, Polypharmacy, Urinary Incontinence, 16%
Palliative Care Pressure Ulcers, End-of-Life Care
Page 2
,Q1. A 78-year-old patient with a history of heart failure with reduced ejection
fraction presents with acute dyspnea, hypoxia, and pulmonary edema. Which initial
intervention is most appropriate?
A. Noninvasive positive pressure ventilation (NIPPV)
B. Intravenous furosemide 40 mg bolus
C. Immediate endotracheal intubation
D. Sublingual nitroglycerin 0.4 mg
Correct Answer: A. Noninvasive positive pressure ventilation (NIPPV)
Rationale: NIPPV is first-line for acute cardiogenic pulmonary edema as it rapidly
improves oxygenation and reduces preload/afterload, often preventing intubation.
Furosemide and nitroglycerin are important but secondary to immediate respiratory
support. Intubation is reserved for failure of NIPPV or severe respiratory failure.
Why Wrong:
B - Diuretics take time to work and are not the immediate priority in acute respiratory
distress.
C - Intubation is invasive and only indicated if NIPPV fails or the patient is unable to
protect the airway.
D - Nitroglycerin helps reduce preload but does not address hypoxia directly and may
cause hypotension.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 25; Yancy
et al. (2017) HF Guidelines.
Q2. A 65-year-old patient with type 2 diabetes and CKD stage 3 is started on an
SGLT2 inhibitor. Which mechanism primarily contributes to its renoprotective
effect?
A. Reduction in intraglomerular pressure via tubuloglomerular feedback
B. Direct inhibition of the renin-angiotensin-aldosterone system
C. Increase in insulin sensitivity in peripheral tissues
D. Stimulation of erythropoietin release from renal fibroblasts
Correct Answer: A. Reduction in intraglomerular pressure via tubuloglomerular
feedback
Rationale: SGLT2 inhibitors reduce proximal tubular sodium reabsorption, increasing
distal sodium delivery to the macula densa, which triggers afferent arteriolar
vasoconstriction (tubuloglomerular feedback) and lowers intraglomerular pressure,
conferring renoprotection. They do not directly inhibit RAAS or increase insulin sensitivity
as a primary mechanism; erythropoietin increase is secondary.
Why Wrong:
B - SGLT2 inhibitors do not directly block RAAS; their effects are independent of that
pathway.
Page 3
, C - Improved insulin sensitivity is a metabolic effect, not the main renoprotective
mechanism.
D - Erythropoietin increase is a minor effect, not the primary renoprotective
mechanism.
Reference: Heerspink, H.J.L., et al. (2020). N Engl J Med; ADA Standards of Care (2026).
Q3. A 72-year-old patient on warfarin for atrial fibrillation presents with an INR of
5.2 and minor bleeding. What is the most appropriate management?
A. Hold warfarin and administer oral vitamin K 2.5 mg
B. Administer fresh frozen plasma (FFP) immediately
C. Give prothrombin complex concentrate (PCC) 25 units/kg
D. Hold warfarin and observe without vitamin K
Correct Answer: A. Hold warfarin and administer oral vitamin K 2.5 mg
Rationale: In patients with INR >5 and minor bleeding, guidelines recommend
withholding warfarin and giving oral vitamin K (1-2.5 mg) to accelerate INR reduction.
FFP and PCC are reserved for life-threatening bleeding or major hemorrhage requiring
rapid reversal. Observation alone is insufficient given bleeding risk.
Why Wrong:
B - FFP is indicated for major bleeding or when rapid reversal is needed; not for
minor bleeding with elevated INR.
C - PCC is for life-threatening bleeding or emergency surgery, not minor bleeding.
D - Observation alone is insufficient; vitamin K is needed to lower INR in a timely
manner.
Reference: January, C.T., et al. (2019). AHA/ACC/HRS Atrial Fibrillation Guidelines.
Q4. A patient with COPD and chronic hypercapnia presents with an acute
exacerbation. Which arterial blood gas finding is most consistent with an
acute-on-chronic respiratory acidosis?
A. pH 7.32, PaCO2 60 mmHg, HCO3- 30 mEq/L
B. pH 7.25, PaCO2 55 mmHg, HCO3- 24 mEq/L
C. pH 7.40, PaCO2 45 mmHg, HCO3- 26 mEq/L
D. pH 7.45, PaCO2 30 mmHg, HCO3- 20 mEq/L
Correct Answer: A. pH 7.32, PaCO2 60 mmHg, HCO3- 30 mEq/L
Rationale: Acute-on-chronic respiratory acidosis is characterized by a low pH, elevated
PaCO2, and a compensatory increase in HCO3- (due to chronic retention). Option A
shows pH 7.32 (acidemia), PaCO2 60 (high), and HCO3- 30 (elevated), consistent with
chronic compensation plus acute worsening. Option B shows normal HCO3- indicating
acute uncompensated; C is normal; D is alkalosis.
Page 4